Skip to main content

Table 4 Kidney function parameters in early and late pregnancy together with the relative changes that occurred during pregnancy

From: Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function

 

Early

Late

 

Change during pregnancy, (%)

Median

5th and 95th percentiles

Median

5th and 95th percentiles

p-value

Median

5th and 95th percentiles

Marker

 Plasma creatinine (μmol/L)

57

45; 67

58

46; 72

0.004

4

−11; 23

 Plasma cystatin C (mg/L)

0.63

0.55; 0.79

1.05

0.77; 1.38

< 0.001

65

26; 116

eGFR (mL/min/1.73m2)

 LMrev

104

90; 120

102

86; 118

0.004

− 2

−12; 8

 CKD-EPIcreatinine

119

102; 131

119

96; 130

0.003

−1

−16; 5

 CAPA

136

104; 160

76

54; 108

< 0.001

−44

−59; −23

 CKD-EPIcystatin C

123

109; 133

76

53; 112

< 0.001

−38

− 57; −12

 Mean of LMrev and CAPA

120

101; 140

89

72; 112

< 0.001

−24

−35; −13

 Mean of CKD-EPIcreatinine and CKD-EPIcystatin C

121

110; 130

97

78; 118

< 0.001

−20

−31; −7

eGFRcystatin C/eGFRcreatininea

 CAPA/LMrev

1.3

1.0; 1.5

0.7

0.5; 1.0

< 0.001

−40

−60; −24

 CKD-EPIcystatin C/CKD-EPIcreatinine

1.0

0.9; 1.1

0.7

0.5; 0.9

< 0.001

−35

−55; −13

  1. aeGFRcystatin C/eGFRcreatinine ≤ 0.6 defines Shrunken pore syndrome